CITY OF VACAVILLE WELCOME AXIOM SITE
VACAVILLE – Transwestern Ventures (TWV), in partnership with Transwestern Real Estate Services (TRS), announces that the Vacaville City Planning Commission has approved plans to develop Axiom Point, a 375,000-square-foot, biomanufacturing state- of-the-art. on campus. The new development will be located on 22.4 acres in the Vaca Valley Business Park at the interchange of I-80 and I-505. Axiom Point is the first life sciences campus to benefit from the Biotechnology and Advanced Manufacturing Initiative, boasting a Biotechnology Acceleration Program that commits the City to implementing a Rights Plan in 100 days or less.
“Vacaville has the land, infrastructure, and workforce that the biotechnology industry needs to grow, and a long-term commitment to a streamlined and conflict-free system,” said Vacaville City Mayor Ron Rowlett. “We are building on our proven success with the industry to secure Vacaville’s continued leadership as a biomanufacturing center going forward, and we are fortunate that Transwestern sees the potential and value of investing in Vacaville. We look forward to the ongoing project. “
A development by Transwestern Ventures, Axiom Point will offer two phases, the first comprising 252,000 square feet and the second comprising 123,000 square feet. Designed to be highly flexible, the project is suited to the needs of residents including bioengineering, laboratory research and development, medical device manufacturing, food science, agricultural technology and healthcare.
“We’re excited to move forward with Axiom Point,” said Transwestern Managing Director Ken Meyersieck, who, along with Lab + Life Sciences experts Peter Conte and Andrew Wheeler, oversees the project’s leasing. “The City of Vacaville has been a great partner, providing excellent guidance and graciously agreeing to the project. We are proud to offer this dynamic biomanufacturing campus in a region known for extraordinary talent and innovation. “
“Transwestern officially submitted our application in early September and it was approved by the Planning Commission less than 90 days later,” said Fred Knapp, Managing Director of Transwestern Ventures. “These impressive changes are a testament to the City of Vacaville’s focus and commitment to making biomanufacturing a cornerstone of its economic development strategy.”
Because of its prime location, Vaca Valley Business Park has become home to life science companies such as Genentech, Johnson & Johnson, RxDNova, Agenus and Polaris.